Hsiao-Ying Chou
Overview
Explore the profile of Hsiao-Ying Chou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
174
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang C, Wu T, Chen Y, Chou H, Wang J, Chuang K, et al.
ACS Appl Mater Interfaces
. 2025 Jan;
17(4):6887-6900.
PMID: 39828983
With increasing energy demands, the need for coating materials with exceptional superhydrophobic properties has grown substantially. However, the widespread use of fluorinated compounds, solvents, and polymer-based synthetic materials has led...
2.
Chuang S, Chen K, Cheng Y, Chen Y, Lin S, Chou H, et al.
Int J Biol Macromol
. 2024 Sep;
280(Pt 3):135894.
PMID: 39322160
Glioblastoma multiforme (GBM) is an aggressive and common brain tumor. The blood-brain barrier prevents several treatments from reaching the tumor. This study proposes a Chemo-Immunotherapy synergy treatment chemically crosslinked hydrogel...
3.
Hanurry E, Birhan Y, Darge H, Mekonnen T, Arunagiri V, Chou H, et al.
ACS Biomater Sci Eng
. 2022 Jun;
8(6):2403-2418.
PMID: 35649177
The efficiency of chemotherapy is frequently affected by its multidrug resistance, immune suppression, and severe side effects. Its combination with immunotherapy to reverse immune suppression and enhance immunogenic cell death...
4.
Wu S, Chou H, Tsai H, Anbazhagan R, Yuh C, Yang J, et al.
RSC Adv
. 2022 May;
10(35):20682-20690.
PMID: 35517745
The use of nanomaterials for drug delivery offers many advantages including the targeted delivery of drugs and their controlled release. Nonetheless, entry into the target cells remains a challenge for...
5.
Mekonnen T, Darge H, Tsai H, Birhan Y, Hanurry E, Gebrie H, et al.
Colloids Surf B Biointerfaces
. 2022 Feb;
213:112391.
PMID: 35158218
Enhancement of drug efficacy is essential in cancer treatment. The immune stimulator ovalbumin (Ova)-coated citric acid (AC-)-stabilized iron oxide nanoparticles (AC-IO-Ova NPs) and enhanced permeability and retention (EPR)-based tumor targeted...
6.
Addisu K, Hsu W, Hailemeskel B, Andrgie A, Chou H, Yuh C, et al.
ACS Biomater Sci Eng
. 2021 Jan;
5(10):5453-5469.
PMID: 33464065
Integrating anticancer drugs and diagnostic agents in a polymer nanosystem is an emerging and promising strategy for improving cancer treatment. However, the development of multifunctional nanoparticles (NPs) for an "all-in-one"...
7.
Chou H, Tsai H
Mater Sci Eng C Mater Biol Appl
. 2020 Dec;
118:111364.
PMID: 33254983
The biocompatibility, flexibility, and tissue-like mechanical properties of hydrogels suggest they are promising materials for wearable devices. However, the production of smart, self-healing hydrogels is limited by the unstable structure...
8.
Mekonnen T, Andrgie A, Darge H, Birhan Y, Hanurry E, Chou H, et al.
Pharmaceutics
. 2020 Nov;
12(11).
PMID: 33182410
Maximizing the antitumor efficacy of doxorubicin (DOX) with a new drug delivery strategy is always desired in the field of biomedical science. Because the clinical applications of DOX in the...
9.
Andrgie A, Darge H, Mekonnen T, Birhan Y, Hanurry E, Chou H, et al.
Polymers (Basel)
. 2020 Nov;
12(11).
PMID: 33172099
Hydrogels have been investigated as ideal biomaterials for wound treatment owing to their ability to form a highly moist environment which accelerates cell migration and tissue regeneration for prompt wound...
10.
Chou H, Weng C, Lai J, Lin S, Tsai H
Polymers (Basel)
. 2020 Sep;
12(9).
PMID: 32962070
Polymer-based hydrogels demonstrate superior performance when used as wound dressing. An ideal dressing should possess an active healing function, absorb wound exudates, and provide a moist interface on the wound...